Human islet amyloid polypeptide‐induced β‐cell cytotoxicity is linked to formation of α‐sheet structure
Protein Science · 2024
DOI: 10.1002/pro.4854 ↗At a glance
Journal article in Protein Science, 2024. Written by Cheng-Chieh Hsu and 7 co-authors. Institution: Department of Bioengineering, University of Washington, Seattle, Washington, USA. Major MEDLINE topics: Diabetes Mellitus, Type 2, Insulin-Secreting Cells. Cited 10 times so far (Crossref); 54 references. The full text is freely available in PubMed Central. Funded by: BLRD VA, NIBIB NIH HHS, NIH HHS.
Abstract (original language)
Type 2 diabetes (T2D) results from insulin secretory dysfunction arising in part from the loss of pancreatic islet β‐cells. Several factors contribute to β‐cell loss, including islet amyloid formation, which is observed in over 90% of individuals with T2D. The amyloid is comprised of human islet amyloid polypeptide (hIAPP). Here we provide evidence that early in aggregation, hIAPP forms toxic oligomers prior to formation of amyloid fibrils. The toxic oligomers contain α‐sheet secondary structure, a nonstandard secondary structure associated with toxic oligomers in other amyloid diseases. De novo, synthetic α‐sheet compounds designed to be nontoxic and complementary to the α‐sheet structure in the toxic oligomers inhibit hIAPP aggregation and neutralize oligomer‐mediated cytotoxicity in cell‐based assays. In vivo administration of an α‐sheet design to mice for 4 weeks revealed no evidence of toxicity nor did it elicit an immune response. Furthermore, the α‐sheet designs reduced endogenous islet amyloid formation and mitigation of amyloid‐associated β‐cell loss in cultured islets isolated from an hIAPP transgenic mouse model of islet amyloidosis. Characterization of the involvement of α‐sheet in early aggregation of hIAPP and oligomer toxicity contributes to elucidation of the molecular mechanisms underlying amyloid‐associated β‐cell loss.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Bioengineering, University of Washington, Seattle, Washington, USA.
- Molecular Engineering Program, University of Washington, Seattle, Washington, USA.
- Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington, USA.
- Department of Biochemistry, University of Washington, Seattle, Washington, USA.
Funding
- BLRD VA
- NIBIB NIH HHS
- NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- American Diabetes Association
- National Institutes of Health
- U.S. Department of Veterans Affairs
Cite
APA
Hsu, C. C., Templin, A. T., Prosswimmer, T., Shea, D., Li, J., Brooks-Worrell, B., Kahn, S. E., & Daggett, V. (2024). Human islet amyloid polypeptide‐induced β‐cell cytotoxicity is linked to formation of α‐sheet structure. Protein Science. https://doi.org/10.1002/pro.4854
Vancouver
Hsu CC, Templin AT, Prosswimmer T, Shea D, Li J, Brooks-Worrell B, et al. Human islet amyloid polypeptide‐induced β‐cell cytotoxicity is linked to formation of α‐sheet structure. Protein Science. 2024. doi:10.1002/pro.4854
BibTeX
@article{Hsu2024,
author = {Hsu, Cheng-Chieh and Templin, Andrew T and Prosswimmer, Tatum and Shea, Dylan and Li, Jinzheng and Brooks-Worrell, Barbara and Kahn, Steven E and Daggett, Valerie},
title = {Human islet amyloid polypeptide‐induced β‐cell cytotoxicity is linked to formation of α‐sheet structure},
journal = {Protein Science},
year = {2024},
doi = {10.1002/pro.4854}
}
EUVIMED